APLAR

Progress in targeted therapy for lupus

Covid and RMD patients in Europe

Drug holiday boosts rheuma patient covid vax success: latest ACR update

APLAR 2021 preview

Treat depression and anxiety for better PsA outcomes

Game-changing RA drugs out of Third World’s reach

Move over, RCT

APLAR interviews: RA treatment in 2030
